The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Unlike opioid medications, which dull the sensation of pain in the brain ... On a well-known rating scale that runs from 0 to 10, the study participants started with pain of about seven, on ...

Physician empathy has long been recommended — but not required — in the doctor-patient relationship.However, for a growing ...

The US Food and Drug Administration (FDA) has approved a new pain medication, suzetrigine ... reducing pain by an average of 3.5 points on a scale of 0 to 10. However, its efficacy in treating ...

However, advancements in research on analgesics — medications to treat pain — and the ongoing opioid addiction epidemic have underscored efforts to establish new protocols. Now, findings from a new ...